Mystery condition destroys three generations of Machakos family

A mysterious degenerative condition afflicting three generations of a Machakos family has brought into sharp focus a critical vulnerability in East Africa's healthcare ecosystem: the absence of accessible diagnostic infrastructure for rare and genetic diseases. The condition, which progressively robs victims of mobility, speech, and vision before proving fatal, remains undiagnosed despite the family's attempts to seek treatment across multiple healthcare facilities. This case is not an isolated incident but rather a window into a systemic challenge affecting millions across sub-Saharan Africa. Approximately 300 million people in Africa lack access to adequate diagnostic services, according to World Health Organization estimates. In Kenya specifically, genetic and rare disease diagnosis remains concentrated in private urban centers, with rural areas like Machakos experiencing severe diagnostic deserts. The family's experience—moving between local clinics, regional hospitals, and private practitioners without conclusive diagnosis—reflects a pattern repeated across the continent. For European investors and entrepreneurs, this situation presents both a cautionary tale about market risks and a compelling business opportunity. Healthcare infrastructure deficits in East Africa create operational challenges for multinational companies but simultaneously represent one of the most underserved market segments on the continent. **Market Context and Investment Implications** Kenya's healthcare sector grows at approximately 8-10%